Evaluation of a topical interferon inducer in experimental influenza infection in volunteers.

Antimicrobial Agents and Chemotherapy
R G DouglasF K Roth

Abstract

The prophylactic and/or therapeutic effect of a low-molecular-weight interferon inducer, CP-20,961, was tested in a double-blind placebo controlled study of experimental influenza A/England/42/72 (H(3)N(2)) infection in normal volunteers. Ten volunteers received CP-20,961 and 10 received placebo. Interferon was detected in nasal secretions of nine of the former and three of the latter group (P < 0.05). Seven in each group became ill, and severity of illness was not different. Also, quantitative virus shedding patterns and antibody response were not different between the two groups. The negative result may have been due to the relatively low quantities of interferon induced.

References

Feb 28, 1972·JAMA : the Journal of the American Medical Association·D A HillR M Chanock
Mar 1, 1974·Infection and Immunity·R G Douglas, R F Betts
Jun 11, 1974·The New England Journal of Medicine·C PanusarnG G Jackson

❮ Previous
Next ❯

Citations

Jan 1, 1979·Journal of Medical Virology·J W LittleF K Roth
Nov 1, 1983·Antiviral Research·Z M ZhengG D Hsiung
Oct 1, 1995·American Journal of Respiratory and Critical Care Medicine·M A Horisberger
Jun 18, 2014·Current Opinion in Immunology·Daniela Frasca, Bonnie B Blomberg
Jan 5, 2011·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Amber M Smith, Alan S Perelson
May 22, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shobana Balasingam, Annelies Wilder-Smith
Jan 31, 2008·American Journal of Epidemiology·Fabrice CarratAlain-Jacques Valleron
Jan 1, 1978·Arthritis and Rheumatism·Y H Chang, C M Pearson
Feb 6, 2013·The American Journal of Tropical Medicine and Hygiene·Olga D LorenziKay M Tomashek
May 9, 2019·Frontiers in Cellular and Infection Microbiology·Amy Caryn ShermanNadine Rouphael
Jul 26, 2018·Frontiers in Microbiology·Amanda P SmithAmber M Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.